Phibro Animal Health Expects FY25 Net Sales Of $1.04B - $1.09B, Est $1.13B
Portfolio Pulse from Benzinga Newsdesk
Phibro Animal Health has provided its financial outlook for FY25, expecting net sales between $1.04 billion and $1.09 billion, which is below the estimated $1.13 billion. The company also anticipates adjusted EBITDA to range from $118 million to $126 million.
August 28, 2024 | 8:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Phibro Animal Health's FY25 financial outlook indicates lower-than-expected net sales, projecting $1.04B-$1.09B against an estimate of $1.13B. Adjusted EBITDA is expected to be $118M-$126M.
The projected net sales for FY25 are below market estimates, which could lead to a negative short-term impact on Phibro Animal Health's stock price. The adjusted EBITDA range also suggests potential challenges in profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100